TERESA OROPILLA-KIEFER: Open Payments
NPI 1215087036 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$127 in 6 payments from 5 companies in 2025. Trend: 2023 $267 · 2024 $396 · 2025 $127
Food & beverage: $127
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Alkermes, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Indivior Inc. | 1 | $17 |
Products named: INGREZZA, ARISTADA, INVEGA SUSTENNA, CAPLYTA, SUBLOCADE.
Industry payments across KY — which companies pay providers there.
